Form 4 for AURA Aura Biosciences, Inc.
Accepted 2026-09-01 17:23:08 ET · period of report 2026-09-01 · accession 0002042910-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-01 17:23 | 2026-09-01 | AURA | Elazzouzi Amy | SVP, Fin, PAO | A - Grant | $0.00 | +23.5K | 143.6K | +20% | $0 |
| D | 2026-09-01 17:23 | 2026-09-01 | AURA | Elazzouzi Amy | SVP, Fin, PAO | A - Grant | $0.00 | +46.5K | 46.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | A | A | 23,540 | $0.00 | 143,600 | D | — | — | (F1) The reported transaction represents a grant of restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-09-01 | A | A | 46,460 | $0.00 | 46,460 | D | $7.43 · — to 2036-09-01 | 46,460 Common Stock | (F2) The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026. |